联环药业子公司艾司唑仑片通过一致性评价

Core Viewpoint - The announcement indicates that Lianhuan Pharmaceutical's subsidiary, Changle Pharmaceutical, has received approval from the National Medical Products Administration for the supplemental application of Estazolam tablets, confirming the drug's consistency in quality and efficacy as a generic medication [1] Group 1: Company Information - Lianhuan Pharmaceutical's subsidiary, Changle Pharmaceutical, has been granted approval for Estazolam tablets [1] - Estazolam is primarily used for treating anxiety and insomnia, and it also serves other purposes such as addressing tension, fear, and as an anticonvulsant [1] - The drug is classified as a commonly used benzodiazepine sedative-hypnotic medication [1]